Wednesday 4 November 2026
Export DLB’s income statement to Excel — free account
Dolby Laboratories
DLB Industrials Specialty Business Services
Dolby Laboratories' revenue for fiscal 2025 (year ended September 2025) was $1.3 billion, up 5.92% from fiscal 2024.
- Revenue
- −3.34%
- EPS
- −37.5%
- Free cash flow
- +157.4%
Quarter to June 2026, against a year earlier
64.77
1.45
+2.29%
Follow DLB
Alert me
Dolby Laboratories (DLB) Total debt
Dolby Laboratories's total debt at the end of fiscal 2023 was $51.0M, unchanged from fiscal 2022. Dolby Laboratories ranks 26th of 44 Specialty Business Services companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2023 | $51.0M | 0.00% |
| FY2022 | $51.0M | (29.17%) |
| FY2021 | $72.0M | (11.11%) |
| FY2020 | $81.0M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2023 | $51.0M | 0.00% |
| Jun 2023 | $51.0M | 6.25% |
| Mar 2023 | $48.0M | 2.13% |
| Dec 2022 | $47.0M | (7.84%) |
| 12 more quarters | Free account |
Total debt against peers
| Company | Total debt |
|---|---|
| RTO Rentokil Initial PLC compare | $5.5B |
| AMTM Amentum Holdings, Inc. compare | $3.8B |
| FA First Advantage Corporation compare | $2.0B |
| ABM ABM Industries Incorporated compare | $1.8B |
| MMS Maximus, Inc. compare | $1.6B |
| CBZ CBIZ, Inc. compare | $1.4B |
| AZZ AZZ Inc. compare | $468.5M |
| UNF Unifirst Corporation compare | $67.0M |
| DLB Dolby Laboratories | $51.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on DLB
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement